New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 26, 2023 - Coherus announced the FDA approval of Udenyca Onbody (pegfilgrastim-cbqv), biosimilar to Neulasta® Onpro® (pegfilgrastim) kit.
Download PDF
Return to publications
